CNPAX
Price
$72.76
Change
-$1.21 (-1.64%)
Updated
Nov 13 closing price
Net Assets
165.22B
MGFYX
Price
$10.72
Change
-$0.18 (-1.65%)
Updated
Nov 13 closing price
Net Assets
154.51M
Interact to see
Advertisement

CNPAX vs MGFYX

Header iconCNPAX vs MGFYX Comparison
Open Charts CNPAX vs MGFYXBanner chart's image
American Funds New Perspective 529A
Price$72.76
Change-$1.21 (-1.64%)
VolumeN/A
Net Assets165.22B
MassMutual Global Svc
Price$10.72
Change-$0.18 (-1.65%)
VolumeN/A
Net Assets154.51M
CNPAX vs MGFYX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MGFYX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and MGFYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 165B vs. MGFYX (155M). CNPAX pays higher dividends than MGFYX: CNPAX (0.45) vs MGFYX (0.00). CNPAX was incepted earlier than MGFYX: CNPAX (24 years) vs MGFYX (21 years). MGFYX (1.13) is less costly to investors than CNPAX (0.77). CNPAX is a more actively managed with annual turnover of: 24.00 vs. MGFYX (6.00). MGFYX has a lower initial minimum investment than CNPAX: MGFYX (0) vs CNPAX (250). CNPAX annual gain was more profitable for investors over the last year : 14.57 vs. MGFYX (-0.73). CNPAX return over 5 years is better than : 34.72 vs. MGFYX (-33.01).
CNPAXMGFYXCNPAX / MGFYX
Total Expense Ratio0.771.1368%
Annual Report Gross Expense Ratio0.771.1368%
Fund Existence24 years21 years-
Gain YTD21.20315.344138%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets165B155M106,452%
Annual Yield % from dividends0.450.00-
Returns for 1 year14.57-0.73-2,000%
Returns for 3 years51.76-9.32-555%
Returns for 5 years34.72-33.01-105%
Returns for 10 years109.86-22.89-480%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX21.760.04
+0.18%
Saratoga Health & Biotechnology A
JBAFX32.730.05
+0.15%
JHancock Balanced R4
HRCCX34.070.02
+0.06%
Carillon ClariVest Capital Apprec C
HOOTX32.240.02
+0.06%
Hartford Schroders US Small Cap Opps R5
FASPX48.93N/A
N/A
Fidelity Advisor Value Strategies M